| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $159.9M | +163.0% |
| Cost of Revenue | $129.2M | +79.0% |
| Gross Profit | $30.7M | +369.8% |
| R&D Expense | $200.1M | +33.9% |
| SG&A Expense | $91.2M | +94.8% |
| Operating Income | -$260.7M | -24.5% |
| Interest Expense | $15.9M | -36.9% |
| Pre-tax Income | -$335.5M | -45.1% |
| Income Tax | -$37.1M | — |
| Net Income | -$298.3M | -29.1% |
| EPS (Basic) | -$4.83 | +76.7% |
| EPS (Diluted) | -$4.83 | +76.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $793.0M | +542.4% |
| Short-term Investments | $100.0M | — |
| Accounts Receivable | $46.1M | +4494.5% |
| Current Assets | $963.2M | +433.0% |
| Total Assets | $1.82B | +348.0% |
| Current Liabilities | $213.6M | +19.1% |
| Total Liabilities | $635.0M | +52.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$204.9M | -30.0% |
| Capital Expenditures | $32.8M | +0.4% |
| Investing Cash Flow | -$401.6M | -1128.1% |
| Financing Cash Flow | $1.26B | +442.1% |
| Free Cash Flow | -$237.8M | -24.9% |
| $1.19B |
| +255.0% |